This is the second webinar in the BioMedical SIG webinar series, “From Research to Development – Paths to Cross the Valley of Death in Life Sciences”, which showcases initiatives available to European KTOs to maturate technologies with potential in TRL and CRL, without the creation of a spin-off.
In this session, speakers Peter Nussbaumer and Gernot Faustmann will present the KHAN/w4i/LDC initiative. This collaborative drug discovery platform facilitates the translation of world-class science into innovative therapies for the benefit of patients. Their mission is to create value through cooperative drug development partnerships with academic innovators in Europe. They focus on first-in-class therapies for attractive markets with a high unmet medical need.
This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.
A lot of fruitful discussions with experienced peers. Very helpful sessions.
Sara Matt-Leubner
University of Innsbruck, Austria
Just perfect 3 days full of information and perfect communication.
Petr Kubečka
Palacký University Olomouc, Czech Republic
From day one ASTP has been a tremendous help. Learning throughs seminars and workshops or meeting peers for discussions, there is always someone around to exchange ideas with.
Paul van Dun
KU Leuven, Belgium
ASTP has attained a unique position that has turned it into a highly valued player on the global technology transfer scene.
Koenraad Debackere
KU Leuven, Belgium
International presence is amazing, so many countries, universities... represented here!!
Christian Massus
SATT Aquitaine, France
Join our newsletter and get the latest news